AIMI — AIM ImmunoTech Cashflow Statement
0.000.00%
Last trade - 00:00- $6.14m
- $4.47m
- $0.17m
Annual cashflow statement for AIM ImmunoTech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -14.4 | -19.1 | -19.4 | -29 | -17.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 2.69 | 3.49 | 2.12 | 0.326 | 1.89 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.605 | 0.895 | 0.966 | 7.13 | 0.296 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -10.4 | -14 | -16.1 | -21.3 | -14.9 |
| Capital Expenditures | -0.595 | -0.633 | -0.271 | -0.585 | -0.018 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -8.57 | 0.002 | 11.3 | -0.247 | 4.72 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -9.16 | -0.631 | 11 | -0.832 | 4.71 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 56.6 | 8.19 | 0.08 | 0.485 | 6.44 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 37 | -6.41 | -5.04 | -21.6 | -3.74 |